
COSCIENS Biopharma Inc
TSX:CSCI

COSCIENS Biopharma Inc?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
Energy
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
3.43
5.98
|
Price Target |
|
We'll email you a reminder when the closing price reaches CAD.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
![]() |
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does COSCIENS Biopharma Inc hold over its rivals?
What risks and challenges
does COSCIENS Biopharma Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of COSCIENS Biopharma Inc.
Provide an overview of the primary business activities
of COSCIENS Biopharma Inc.
What unique competitive advantages
does COSCIENS Biopharma Inc hold over its rivals?
What risks and challenges
does COSCIENS Biopharma Inc face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for COSCIENS Biopharma Inc.
Provide P/S
for COSCIENS Biopharma Inc.
Provide P/E
for COSCIENS Biopharma Inc.
Provide P/OCF
for COSCIENS Biopharma Inc.
Provide P/FCFE
for COSCIENS Biopharma Inc.
Provide P/B
for COSCIENS Biopharma Inc.
Provide EV/S
for COSCIENS Biopharma Inc.
Provide EV/GP
for COSCIENS Biopharma Inc.
Provide EV/EBITDA
for COSCIENS Biopharma Inc.
Provide EV/EBIT
for COSCIENS Biopharma Inc.
Provide EV/OCF
for COSCIENS Biopharma Inc.
Provide EV/FCFF
for COSCIENS Biopharma Inc.
Provide EV/IC
for COSCIENS Biopharma Inc.
What are the Revenue projections
for COSCIENS Biopharma Inc?
How accurate were the past Revenue estimates
for COSCIENS Biopharma Inc?
What are the Net Income projections
for COSCIENS Biopharma Inc?
How accurate were the past Net Income estimates
for COSCIENS Biopharma Inc?
What are the EPS projections
for COSCIENS Biopharma Inc?
How accurate were the past EPS estimates
for COSCIENS Biopharma Inc?
What are the EBIT projections
for COSCIENS Biopharma Inc?
How accurate were the past EBIT estimates
for COSCIENS Biopharma Inc?
Compare the revenue forecasts
for COSCIENS Biopharma Inc with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of COSCIENS Biopharma Inc and its key competitors using the latest financial data.
Compare historical revenue growth rates
of COSCIENS Biopharma Inc against its competitors.
Analyze the profit margins
(gross, operating, and net) of COSCIENS Biopharma Inc compared to its peers.
Compare the P/E ratios
of COSCIENS Biopharma Inc against its peers.
Discuss the investment returns and shareholder value creation
comparing COSCIENS Biopharma Inc with its peers.
Analyze the financial leverage
of COSCIENS Biopharma Inc compared to its main competitors.
Show all profitability ratios
for COSCIENS Biopharma Inc.
Provide ROE
for COSCIENS Biopharma Inc.
Provide ROA
for COSCIENS Biopharma Inc.
Provide ROIC
for COSCIENS Biopharma Inc.
Provide ROCE
for COSCIENS Biopharma Inc.
Provide Gross Margin
for COSCIENS Biopharma Inc.
Provide Operating Margin
for COSCIENS Biopharma Inc.
Provide Net Margin
for COSCIENS Biopharma Inc.
Provide FCF Margin
for COSCIENS Biopharma Inc.
Show all solvency ratios
for COSCIENS Biopharma Inc.
Provide D/E Ratio
for COSCIENS Biopharma Inc.
Provide D/A Ratio
for COSCIENS Biopharma Inc.
Provide Interest Coverage Ratio
for COSCIENS Biopharma Inc.
Provide Altman Z-Score Ratio
for COSCIENS Biopharma Inc.
Provide Quick Ratio
for COSCIENS Biopharma Inc.
Provide Current Ratio
for COSCIENS Biopharma Inc.
Provide Cash Ratio
for COSCIENS Biopharma Inc.
What is the historical Revenue growth
over the last 5 years for COSCIENS Biopharma Inc?
What is the historical Net Income growth
over the last 5 years for COSCIENS Biopharma Inc?
What is the current Free Cash Flow
of COSCIENS Biopharma Inc?
Discuss the annual earnings per share (EPS)
trend over the past five years for COSCIENS Biopharma Inc.
P/S
Price to Sales
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
Market Cap | P/S | ||||
---|---|---|---|---|---|
CA |
![]() |
COSCIENS Biopharma Inc
TSX:CSCI
|
11.1m CAD | 0.9 | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 563 902.2 |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
390.2B USD | 6.7 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
148B USD | 4.2 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
140.4B USD | 4.9 |
|
US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 099 |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
98.9B USD | 8.6 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
96B AUD | 4.1 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
63.6B USD | 4.5 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
59.1B USD | 24 |
|
US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 |
|
Revenue Growth | P/S to Growth | |||||
---|---|---|---|---|---|---|
CA |
![]() |
COSCIENS Biopharma Inc
TSX:CSCI
|
Average P/S:
3 051 461.8
0.9
|
N/A | N/A | |
FR |
![]() |
Pharnext SCA
OTC:PNEXF
|
33 563 902.2
|
N/A | N/A |
|
US |
![]() |
Abbvie Inc
NYSE:ABBV
|
6.7
|
9%
|
0.7 |
|
US |
![]() |
Amgen Inc
NASDAQ:AMGN
|
4.2
|
4%
|
1.1 |
|
US |
![]() |
Gilead Sciences Inc
NASDAQ:GILD
|
4.9
|
4%
|
1.2 |
|
US |
E
|
Epizyme Inc
F:EPE
|
2 099
|
N/A | N/A |
|
US |
![]() |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
8.6
|
10%
|
0.9 |
|
AU |
![]() |
CSL Ltd
ASX:CSL
|
4.1
|
6%
|
0.7 |
|
US |
![]() |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
4.5
|
5%
|
0.9 |
|
US |
![]() |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
24
|
41%
|
0.6 |
|
US |
S
|
Seagen Inc
F:SGT
|
20.2
|
30%
|
0.7 |
|
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.